^ Solodovnikov, Alexey; Arkhipova, Valeria. Достоверно красиво: как мы сделали 3D-модель SARS-CoV-2 [Truly beautiful: how we made the SARS-CoV-2 3D model] . N+1 . 29 July 2021 [30 July 2021] . (原始内容 存档于30 July 2021) (俄语) .
^ Shen S, Tan T H P, Tan Y J. Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV[J]. Glycovirology Protocols, 2007: 127-135.
^ Deng, X.; Baker, S.C. Coronaviruses: Molecular Biology (Coronaviridae). Encyclopedia of Virology. 2021: 198–207. ISBN 9780128145166 . doi:10.1016/B978-0-12-814515-9.02550-9 .
^ 4.0 4.1 Masters, Paul S. The Molecular Biology of Coronaviruses . Advances in Virus Research. 2006, 66 : 193–292. ISBN 9780120398690 . PMC 7112330 . PMID 16877062 . doi:10.1016/S0065-3527(06)66005-3 .
^ 5.0 5.1 Wang, Yuhang; Grunewald, Matthew; Perlman, Stanley. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis. Coronaviruses. Methods in Molecular Biology 2203 . 2020: 1–29. ISBN 978-1-0716-0899-9 . PMC 7682345 . PMID 32833200 . doi:10.1007/978-1-0716-0900-2_1 .
^ Huang, Y., Yang, C., Xu, Xf. et al. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 41, 1141–1149 (2020). https://doi.org/10.1038/s41401-020-0485-4
^ Zhu, Chaogeng; He, Guiyun; Yin, Qinqin; Zeng, Lin; Ye, Xiangli; Shi, Yongzhong; Xu, Wei. Molecular biology of the SARs‐CoV‐2 spike protein: A review of current knowledge . Journal of Medical Virology. 14 June 2021, 93 (10): 5729–5741. PMC 8427004 . PMID 34125455 . doi:10.1002/jmv.27132 .
^ 存档副本 . [2022-06-03 ] . (原始内容 存档于2022-02-12).
^ V’kovski, Philip; Kratzel, Annika; Steiner, Silvio; Stalder, Hanspeter; Thiel, Volker. Coronavirus biology and replication: implications for SARS-CoV-2 . Nature Reviews Microbiology. March 2021, 19 (3): 155–170. PMC 7592455 . PMID 33116300 . doi:10.1038/s41579-020-00468-6 .